APA (7th ed.) Citation

M, R., RL, W., KM, S., C, R., PH, F., SE, C., . . . TH, D. (2023). Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA. Annals of surgical oncology, 30(12), 7814. https://doi.org/10.1245/s10434-023-13941-2

Chicago Style (17th ed.) Citation

M, Raoof, et al. "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA." Annals of Surgical Oncology 30, no. 12 (2023): 7814. https://doi.org/10.1245/s10434-023-13941-2.

MLA (9th ed.) Citation

M, Raoof, et al. "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA." Annals of Surgical Oncology, vol. 30, no. 12, 2023, p. 7814, https://doi.org/10.1245/s10434-023-13941-2.